Related references
Note: Only part of the references are listed.Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma
Chuan Lan et al.
BRITISH JOURNAL OF CANCER (2022)
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
Shuichi Aoki et al.
GUT (2022)
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
Renjie Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells
Radwa Ayman Salah et al.
LIFE SCIENCES (2022)
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma
Barbara Chiavarina et al.
ONCOGENE (2022)
PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-O receptor I versus II
Liankang Sun et al.
CELL REPORTS (2022)
CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase
Yuli Lin et al.
HEPATOLOGY (2022)
DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS
Giulia Biffi et al.
PHYSIOLOGICAL REVIEWS (2021)
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma
Nathalie Guedj et al.
MODERN PATHOLOGY (2021)
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Boonyakorn Boonsri et al.
CANCER RESEARCH AND TREATMENT (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Integrative single-cell transcriptome analysis reveals a subpopulation of fibroblasts associated with favorable prognosis of liver cancer patients
Haiyang Wang et al.
TRANSLATIONAL ONCOLOGY (2021)
Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma
Yu Chen et al.
CANCER LETTERS (2021)
Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression
Mengjia Song et al.
HEPATOLOGY (2021)
Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
Zhikui Liu et al.
CELL DEATH & DISEASE (2021)
MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling
Chi-Yu Lai et al.
CANCERS (2021)
Perivenous Stellate Cells Are the Main Source of Myofibroblasts and Cancer-Associated Fibroblasts Formed After Chronic Liver Injuries
Shan-Shan Wang et al.
HEPATOLOGY (2021)
Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
Yijun Wang et al.
CANCERS (2021)
TWEAK/Fn14 signalling promotes cholangiocarcinoma niche
Benjamin J. Dwyer et al.
JOURNAL OF HEPATOLOGY (2021)
Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
Xiaopei Hao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1 alpha-XBP1s pathway
Jia-Wei Wang et al.
CELL DEATH DISCOVERY (2021)
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade
Amber G. Bozward et al.
FRONTIERS IN IMMUNOLOGY (2021)
Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse
Suyanee Thongchot et al.
CANCERS (2021)
Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition
Cong Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations (vol 39, pg 866, 2021)
Silvia Affo et al.
CANCER CELL (2021)
Downregulation of tumor-derived exosomal miR-34c induces cancer-associated fibroblast activation to promote cholangiocarcinoma progress
Xinglei Qin et al.
CANCER CELL INTERNATIONAL (2021)
FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness
Jia-Jian Loh et al.
CANCER RESEARCH (2021)
The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts
Luping Gao et al.
CANCER SCIENCE (2021)
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling
Cindy Lobe et al.
HEPATOLOGY (2021)
Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway
Shuhai Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation
Hongjun Xiao et al.
JOURNAL OF PATHOLOGY (2021)
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis et al.
CANCERS (2021)
Tumor restriction by type I collagen opposes tumor- promoting effects of cancer-associated fibroblasts
Sonakshi Bhattacharjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
Yu Huang et al.
JOURNAL OF CANCER (2021)
Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment
Jiang Li et al.
CARCINOGENESIS (2020)
STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway
Rui Zhang et al.
CANCER SCIENCE (2020)
CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
Xiao-Lu Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma
Betul Gok Yavuz et al.
Oncotarget (2020)
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
Fuming Li et al.
NATURE CELL BIOLOGY (2020)
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Yu-Chin Liu et al.
CELLS (2020)
Spatial proteome profiling by immunohistochemistry-based laser capture microdissection and data-independent acquisition proteomics
Peiwu Huang et al.
ANALYTICA CHIMICA ACTA (2020)
Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma
Fa Yang et al.
CANCER RESEARCH (2020)
Cancer-associated fibroblasts enhance the chemoresistance of CD73(+) hepatocellular carcinoma cancer cells via HGF-Met-ERK1/2 pathway
Hao Peng et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang et al.
JOURNAL OF HEPATOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma
Phuong Thao Nguyen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma
Natasa Pavlovic et al.
ELIFE (2020)
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma
Zhongjian Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)
Cellular Senescence, Represented by Expression of Caveolin-1, in Cancer-Associated Fibroblasts Promotes Tumor Invasion in Pancreatic Cancer
Takanobu Yamao et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2019)
The tumour microenvironment and immune milieu of cholangiocarcinoma
Luca Fabris et al.
LIVER INTERNATIONAL (2019)
p300 Acetyltransferase Is a Cytoplasm-to-Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β-Stimulated Hepatic Stellate Cells
Yuanguo Wang et al.
HEPATOLOGY (2019)
Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP
Liankang Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma
Yohei Mano et al.
JOURNAL OF GASTROENTEROLOGY (2019)
LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation
Anita Moren et al.
ONCOGENESIS (2019)
Peri-tumor fibroblasts promote tumorigenesis and metastasis of hepatocellular carcinoma via Interleukin6/STAT3 signaling pathway
Zhenxiong Zhao et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes
Sangiliyandi Gurunathan et al.
CELLS (2019)
Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy
Zhenxiong Zhao et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis
Yasuyuki Mizutani et al.
CANCER RESEARCH (2019)
The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
C. J. H. Kramer et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
Massimiliano Cadamuro et al.
JOURNAL OF HEPATOLOGY (2019)
Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling
Yawen Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway
Junru Li et al.
ONCOIMMUNOLOGY (2019)
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
Yuli Lin et al.
NEOPLASIA (2019)
Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway
Bin Huang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology
Anna Pellat et al.
HEPATOLOGY (2018)
Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts
Ju Hun Yeon et al.
ACTA BIOMATERIALIA (2018)
FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells
Qin Luo et al.
CANCER LETTERS (2018)
Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis
Hyungjin Rhee et al.
CANCER RESEARCH (2018)
CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression
Yuki Makino et al.
CANCER RESEARCH (2018)
The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
Javier Vaquero et al.
CLINICAL CANCER RESEARCH (2018)
Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy
Ghulam Jilany Khan et al.
CURRENT DRUG TARGETS (2018)
P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts
Changwei Dou et al.
GASTROENTEROLOGY (2018)
被撤回的出版物: IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma (Retracted article. See vol. 123, pg. 1118, 2022)
Zi Yin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cancer-associated fibroblasts induce PDL1+neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
Yusheng Cheng et al.
CELL DEATH & DISEASE (2018)
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
Tian Fang et al.
NATURE COMMUNICATIONS (2018)
The Tumor Microenvironment: A Druggable Target for Metastatic Disease?
[Anonymous]
EBIOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway
Suyanee Thongchot et al.
MOLECULAR CARCINOGENESIS (2018)
The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes
Baojia Zou et al.
JOURNAL OF CANCER (2018)
Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
Yuan Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy
Zeli Yin et al.
MOLECULAR CANCER (2018)
The unfolded protein response and endoplasmic reticulum protein targeting machineries converge on the stress sensor IRE1
Diego Acosta-Alvear et al.
ELIFE (2018)
Emerging therapies in advanced hepatocellular carcinoma
Sowmini Medavaram et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells
Chungang Liu et al.
CANCER RESEARCH (2018)
Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
Y. Deng et al.
ONCOGENE (2017)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma
Xiao-fang Zhang et al.
HUMAN PATHOLOGY (2017)
Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells
Kai Liu et al.
MOLECULAR CELL (2017)
Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane
Alexandros Glentis et al.
NATURE COMMUNICATIONS (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells
Jinghua Jiang et al.
CANCER LETTERS (2017)
The stellate cell system (vitamin A-storing cell system)
Haruki Senoo et al.
ANATOMICAL SCIENCE INTERNATIONAL (2017)
Tumor-associated myeloid cells as guiding forces of cancer cell stemness
Antonio Sica et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver
H. Zhang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment
Genichiro Ishii et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma
Jine Yang et al.
CANCER LETTERS (2016)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling
Xuguang Yang et al.
CANCER RESEARCH (2016)
TGF-β signalling and liver disease
Isabel Fabregat et al.
FEBS JOURNAL (2016)
Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma
Chungang Liu et al.
HEPATOLOGY (2016)
Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation
Annika Wilhelm et al.
JOURNAL OF PATHOLOGY (2016)
BMP signalling in skeletal development, disease and repair
Valerie S. Salazar et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling
Eunice Yuen Ting Lau et al.
CELL REPORTS (2016)
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
J-t Cheng et al.
ONCOGENESIS (2016)
Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
Vincenzo Cardinale et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
Caecilia Hapsari Ceriapuri Sukowati et al.
BMC CANCER (2015)
Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma
Takayuki Kawai et al.
CLINICAL CANCER RESEARCH (2015)
TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma
Tao Song et al.
ONCOTARGET (2015)
CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils
Shao-Lai Zhou et al.
CARCINOGENESIS (2014)
The Portal Fibroblast: Not Just a Poor Man's Stellate Cell
Rebecca G. Wells
GASTROENTEROLOGY (2014)
Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma
Yanmei Han et al.
HEPATOLOGY (2014)
Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma
Jocelyn H. Wright et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma
Laurent Sulpice et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma
Mi Jin Gu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Autophagy contributes to the survival of CD 133+liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment
Yu-jiao Song et al.
CANCER LETTERS (2013)
Platelet-Derived Growth Factor-D and Rho GTPases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
Massimiliano Cadamuro et al.
HEPATOLOGY (2013)
Hepatic Myofibroblasts Promote the Progression of Human Cholangiocarcinoma Through Activation of Epidermal Growth Factor Receptor
Audrey Claperon et al.
HEPATOLOGY (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
Neil C. Henderson et al.
NATURE MEDICINE (2013)
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: A novel in vitro model to study tumor-stroma interactions
Marco Massani et al.
ONCOLOGY REPORTS (2013)
Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion
Chang-Chang Jia et al.
PLOS ONE (2013)
The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
Caecilia Hapsari Ceriapuri Sukowati et al.
PLOS ONE (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Tuanjie Li et al.
CANCER LETTERS (2012)
Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma
Shao-Lai Zhou et al.
HEPATOLOGY (2012)
Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts
Hirohisa Okabe et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma
Alessandra Gentilini et al.
JOURNAL OF HEPATOLOGY (2012)
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
Paula J. Hurley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: Concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers
Syamal D. Bhattacharya et al.
SURGERY (2012)
Mesenchymal Stem Cells
Dah-Ching Ding et al.
CELL TRANSPLANTATION (2011)
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma
Alphonse E. Sirica et al.
CURRENT OPINION IN GASTROENTEROLOGY (2011)
Tumor-Secreted Lysophostatidic Acid Accelerates Hepatocellular Carcinoma Progression by Promoting Differentiation of Peritumoral Fibroblasts in Myofibroblasts
Antonio Mazzocca et al.
HEPATOLOGY (2011)
Caveolin-1, cellular senescence and age-related diseases
Huafei Zou et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2011)
Forkhead transcription factors: key players in health and disease
Berenice A. Benayoun et al.
TRENDS IN GENETICS (2011)
Strong expression of CD133 is associated with increased cholangiocarcinoma progression
Kawin Leelawat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Portal Fibroblasts: Underappreciated Mediators of Biliary Fibrosis
Jonathan A. Dranoff et al.
HEPATOLOGY (2010)
Down-Regulation of Connective Tissue Growth Factor by Inhibition of Transforming Growth Factor β Blocks the Tumor-Stroma Cross-Talk and Tumor Progression in Hepatocellular Carcinoma
Antonio Mazzocca et al.
HEPATOLOGY (2010)
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Kojiro Taura et al.
HEPATOLOGY (2010)
Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model
Suksanti Prakobwong et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
Kusumawadee Utispan et al.
MOLECULAR CANCER (2010)
Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion
Apaporn Menakongka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
The multifaceted role of periostin in tumorigenesis
Kai Ruan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic Mechanisms
Alphonse E. Sirica et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Mert Erkan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Stromal myofibroblasts are drivers of invasive cancer growth
Olivier De Wever et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition
Michael Zeisberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma
Ming-Chih Ho et al.
CANCER LETTERS (2007)
Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion
T Yeung et al.
CELL MOTILITY AND THE CYTOSKELETON (2005)
ER stress and the unfolded protein response
M Schröder et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium
S Christian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
